Terns appoints Ankang Li as CFO

China |  News | 0 Comment | 02 Jul, 2019

Terns Pharmaceuticals, a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer has announ...Read more

Ping An wins top ranking in Global AI Challenge

China |  News | 0 Comment | 02 Jul, 2019

Ping An Insurance (Group) Company of China, Ltd. has received global recognition for its achievements in artificial intelligence (AI) processing of human language in the healthcare fie...Read more

BeiGene gets approval to transit from Biotech chapter of HKEX to a General Listing

China |  News | 0 Comment | 01 Jul, 2019

BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, t...Read more

IDT, ChosenMed to enhance cancer diagnosis in China

China |  News | 0 Comment | 01 Jul, 2019

US based Integrated DNA Technologies (IDT) has announced that is has entered into a strategic cooperation with ChosenMed Technology (Beijing) Co., Ltd (ChosenMed), a medical sequencing...Read more

J&J Innovation opens JLABS @ Shanghai with Shanghai Pharma Engine

China |  News | 0 Comment | 28 Jun, 2019

Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., on 27 June 2019, announced the opening of JLABS @ Shanghai, the world's largest JLABS and t...Read more

Yisheng Biopharma receives IND clearance for treatment of advanced solid tumors

China |  News | 0 Comment | 27 Jun, 2019

Yisheng Biopharma, a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, announced that it has rece...Read more

MicroPort Orthopedics unveils new knee replacement system

China |  News | 0 Comment | 27 Jun, 2019

MicroPort Orthopedics, a medical device company associated with China headquartered MicroPort Scientific Corporation, that develops and manufactures cutting edge joint replacement implants ...Read more

NMPA accepts NDA for biosimilar product candidate of Rituximab

China |  News | 0 Comment | 27 Jun, 2019

Innovent Biologics and Eli Lilly and Company have jointly announced that the National Medical Products Administration (NMPA) has accepted its new drug application (NDA) for IBI301, a co-dev...Read more

Merck builds first Mobile Lab to conduct protein research campaigns

China |  News | 0 Comment | 28 Jun, 2019

Merck, the world's leading technology company, has launched its first “Mobile Lab” on protein research on a national campus. A well-designed and modified truck, intern...Read more

PREMIA, AmoyDx to establish Asia Cancer Clinical Genomic Network

China |  News | 0 Comment | 26 Jun, 2019

Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic partnership agreement with Amoy Diagnostics and PREMIA Holdings (HK) Ltd. Under the ag...Read more

Target Health, dMed Biopharma join forces for rapid internationalization of clinical trials

China |  News | 0 Comment | 25 Jun, 2019

Target Health Inc. and dMed Biopharmaceuticals Company Limited have joined forces to help Western and Chinese biopharma and device companies capitalize on the rapid internationalization of ...Read more

GENFIT, Terns Pharma announce $228M strategic partnership

China |  News | 0 Comment | 25 Jun, 2019

GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases, has ann...Read more

FDA Grants Orphan Drug Designation to XWL-008 to treat Narcolepsy

China |  News | 0 Comment | 25 Jun, 2019

XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel small molecule therapeutics for the treatment of neurological disorder...Read more

BeiGene, SpringWorks Therapeutics form new entity MapKure

China |  News | 0 Comment | 24 Jun, 2019

BeiGene, Ltd., a China headquartered commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treat...Read more

EMA accepts First "China-Developed" Biosimilar - Henlius HLX02 MAA for Review

China |  News | 0 Comment | 24 Jun, 2019

Henlius, a leading biotech company in China developing both biosimilar and innovative biologics, on 21 June 2019, announced that the European Medicines Agency (EMA) has officially...Read more

Asieris Completes Enrolment for US APL-1202 Phase Ib Clinical Trial

China |  News | 0 Comment | 24 Jun, 2019

Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumours and related diseases, on 24 June 20...Read more

FasT CAR-19 Therapy Shows Positive Impact in Patients with (r/r) B-ALL

China |  News | 0 Comment | 21 Jun, 2019

Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announced preliminary results of a multi-centre pilot study d...Read more

WuXi Biologics to expand integrated biologics conjugation solution center

China |  News | 0 Comment | 21 Jun, 2019

WuXi Biologics ("WuXi Bio"), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, on 21 J...Read more